What is Exagen Inc.'s EV / sales?

Exagen Inc. (XGN) reported EV / sales of 1.1× in Q1 2026.

How has Exagen Inc.'s EV / sales changed year-over-year?

Exagen Inc.'s EV / sales decreased by 15.6% year-over-year, from 1.3× to 1.1×.

What is the long-term trend for Exagen Inc.'s EV / sales?

Over 5 years (2020 to 2025), Exagen Inc.'s EV / sales has grown at a -14.6% compound annual growth rate (CAGR), from 4.4× to 2×.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

Exagen Inc. XGN EV / sales

EV / sales at other companies

Labcorp HoldingsLH

2×+0.1×

Quest DiagnosticsDGX

2.4×0.0×

Avalo TherapeuticsAVTX

-127.1×-128×

CareDxCDNA

2×-0.6×

Bio-Rad LaboratoriesBIO

3.1×+0.1×

RevvityRVTY

4.4×-0.9×

Other financials

Income statement

See full

Revenue$17.3M+11.7%

Gross profit$10.2M+11.9%

Operating income-$3.4M-1.5%

Net income-$4.0M-5.7%

EPS (diluted)-$0.17+15.0%

Balance sheet

See full

Cash & equivalents$21.7M+90.6%

Total debt$27.1M+15.8%

Total equity$14.4M+125%

Total assets$52.0M+28.9%

Cash flow

See full

Operating cash flow-$10.4M+2.4%

CapEx$228.0K+102%

Free cash flow-$10.6M+1.3%

Valuation

See full

Market cap$112.34M-26.5%

Enterprise value$117.78M-20.3%

P/S1.6×-1.0×

Profitability

See full

Gross margin58.3%-1.0pp

Operating margin-20.6%-2.9pp

Net margin-29.5%+2.5pp

FCF margin-27.5%—

Returns & leverage

See full

Return on equity-193.6%+355pp

Debt / equity1.9×-1.8×

Current ratio3.5×+1.1×

Where this comes from

Calculated from Exagen Inc.’s reported figures.

enterprise value/total revenue=1.1×

Based on the most recent quarter.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Exagen Inc.'s EV / sales?: Exagen Inc. (XGN) reported EV / sales of 1.1× in Q1 2026.
How has Exagen Inc.'s EV / sales changed year-over-year?: Exagen Inc.'s EV / sales decreased by 15.6% year-over-year, from 1.3× to 1.1×.
What is the long-term trend for Exagen Inc.'s EV / sales?: Over 5 years (2020 to 2025), Exagen Inc.'s EV / sales has grown at a -14.6% compound annual growth rate (CAGR), from 4.4× to 2×.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.